David J. Lennon, Ph.D., has been President of AveXis, a Novartis company, since June 2018.
Mr. Lennon previously was General Manager of Novartis Oncology in Japan. He joined Novartis in 2005 as Head of New Products and Portfolio Strategy, and has held additional positions including Vice President, Solid Tumors franchise for Novartis Oncology in the United States; Chief Marketing Officer of the Greater China region for Novartis Pharmaceuticals; and Vice President, Marketing for the US Neurology and Psychiatry business. Prior to Novartis, Mr. Lennon was an associate principal at McKinsey & Company in New York.
Mr. Lennon holds a doctorate in molecular medicine from Weill Cornell Medicine in the US, and a bachelor’s degree in biophysics from Columbia University in the US.